期刊文献+

大鼠前列腺特异膜抗原基因重组腺病毒诱导小鼠特异性抗体的研究

Immunological Response of Mice Induced by Recombinant Adenovirus Carrying Rat Prostate-specific Membrane Antigen Gene
原文传递
导出
摘要 目的构建含大鼠前列腺特异膜抗原基因(PSMA)的重组腺病毒Ad-rPSMA,并研究其在小鼠体内的特异性体液免疫反应。方法提取大鼠脑组织总RNA,经RT-PCR扩增PSMA基因片段,利用Adeasy腺病毒载体系统构建pAd-rPSMA重组腺病毒质粒,包装复制缺陷型重组腺病毒Ad-rPSMA,制备病毒颗粒。用制备的病毒感染HeLa细胞,Western blot检测PSMA基因的表达。以Ad-rPSMA重组腺病毒免疫C57小鼠,检测血清中PSMA特异性抗体。结果成功构建了含有大鼠PSMA基因的重组腺病毒,制备的病毒颗粒数为1.97×1012VP/mL,A260/A280值为1.32,病毒滴度为5×1010IU/mL;Western blot检测可见大鼠PSMA基因在HeLa细胞中的表达;ELISA法检测出免疫小鼠血清中存在PSMA特异性抗体。结论成功构建了大鼠前列腺特异膜抗原基因重组腺病毒Ad-rPSMA,并诱导小鼠产生了针对PSMA的特异性抗体。 Objective To construct a recombinant adenovirus carrying rat prostate-specific membrane antigen(PSMA) gene and to investigate the immune response of mice to it.Methods PSMA cDNA fragment was amplified by RT-PCR using total RNA extracted from rat brain tissue.Recombinant plasmid pAd-rPSMA was constructed by using adeasy adenovirus vector system.Packaged recombinant adenovirus Ad-rPSMA were obtained.The expression of rat PSMA gene in HeLa cells was confirmed by Western blot.The recombinant adenovirus were applied to C57 mice and the resulting anti sera against PSMA were detected with ELISA.Results Recombinant adenovirus carrying rat PSMA gene was constructed successfully.The virus particle count,A260/A280 value and titer were 1.97×1012 VP/mL,1.32,5×10^10 IU/mL respectively.Western blot analysis proved the expression of rat PSMA gene in HeLa cells.PSMA-specific sera antibody was produced in mice.ConclusionRecombinant adenovirus Ad-rPSMA was constructed and it could induce the mice to produce PSMA-specific antibody.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2011年第2期147-151,共5页 Journal of Sichuan University(Medical Sciences)
基金 国家863重点项目(2007AA021202)资助
关键词 前列腺癌 前列腺特异膜抗原 腺病毒载体 同源异种免疫 Prostate cancer Prostate-specific membrane antigen Adenovirus vector Xenogeneic homologous immunotherapy
  • 相关文献

参考文献13

  • 1Lapidus RG, Tiffany CW, Isaacs JT, et al. Prostate-specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells. Prostate,2000.45(4):350- 354.
  • 2Silver DA, Pelliccr I, Fair WR, et al. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res, 1997 ; 3 : 81-85.
  • 3Sweat SD, Pacelli A, Murphy GP, et al. Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. Urology, 1998 ; 52 (4) :637-640.
  • 4Wright GL Jr, Grob BM, Haley C, et al. Upregulation of prostate-specific membrane antigen after androgen deprivation therapy. Urology, 1996 ;48(2) :326-334.
  • 5Gregor PD, Wolchok JD, Turaga V, et al. Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccination. Int J Cancer, 2005 . 116 ( 3 ) : 415- 421.
  • 6Ren JQ, Zheng L, Chen Q, etal. Co-administration of a DNA vaccine encoding the prostate specific membrane antigen and CpG oligodeoxynucleotides suppresses tumor growth. J Trans Med, 2004 . 2 : 29-38.
  • 7Lubaroff DM, Konety B, Link BK, et al. Clinical protocol: phase I study of an adenovirus/prostate-specific antigen vaccine in men with metastatic prostate cancer. Hum Gene Ther, 2006 ; 17(2) : 220-229.
  • 8Srinivasan R, Wolchok JD. Tumor antigens for immunotherapy: therapeutic potential of xenogeneic DNA vaccines. J Trans Med, 2004 ; 2 : 12-23.
  • 9Disis ML, Shiota FM, Cheever MA. Human HER-2/neu protein immunization circumvents tolerance to rat neu: a vaccine strategy for ' self' tumour antigens. Immunology,1998.93(2):192-199.
  • 10Liu JY, Wei YQ, Yang L, et al. Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor 2. Blood,2003; 102(5) : 1815-1823.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部